David Wright

8.1k total citations · 1 hit paper
244 papers, 5.2k citations indexed

About

David Wright is a scholar working on Geriatrics and Gerontology, General Health Professions and Economics and Econometrics. According to data from OpenAlex, David Wright has authored 244 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Geriatrics and Gerontology, 57 papers in General Health Professions and 35 papers in Economics and Econometrics. Recurrent topics in David Wright's work include Pharmaceutical Practices and Patient Outcomes (73 papers), Health Systems, Economic Evaluations, Quality of Life (32 papers) and Dysphagia Assessment and Management (20 papers). David Wright is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (73 papers), Health Systems, Economic Evaluations, Quality of Life (32 papers) and Dysphagia Assessment and Management (20 papers). David Wright collaborates with scholars based in United Kingdom, United States and Norway. David Wright's co-authors include Richard Holland, Debi Bhattacharya, Jennifer Kelly, James Desborough, Michael Twigg, Jane Carthey, Vernon T. Farewell, Marc R. de Leval, James Reason and Hedvig Nordeng and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

David Wright

225 papers receiving 4.9k citations

Hit Papers

European Stroke Organisation and European Society for Swa... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Wright United Kingdom 38 1.6k 846 669 650 650 244 5.2k
Michael D. Murray United States 49 1.6k 1.0× 1.2k 1.4× 459 0.7× 771 1.2× 295 0.5× 249 7.8k
Andrea Benedetti Canada 44 621 0.4× 604 0.7× 668 1.0× 433 0.7× 122 0.2× 229 7.7k
Juan P. Wisnivesky United States 54 355 0.2× 1.4k 1.6× 407 0.6× 472 0.7× 244 0.4× 282 11.0k
Mieke van Driel Australia 46 443 0.3× 1.8k 2.1× 313 0.5× 632 1.0× 406 0.6× 314 7.5k
Douglas W. Roblin United States 39 267 0.2× 1.5k 1.8× 788 1.2× 471 0.7× 339 0.5× 155 7.3k
Thomas Agoritsas Switzerland 44 576 0.4× 1.6k 1.9× 580 0.9× 972 1.5× 161 0.2× 166 9.3k
Craig M. Lilly United States 38 306 0.2× 1.0k 1.2× 277 0.4× 230 0.4× 1.5k 2.3× 102 7.8k
Philip Ryan Australia 49 427 0.3× 831 1.0× 1.1k 1.6× 567 0.9× 146 0.2× 165 9.3k
Adit A. Ginde United States 42 251 0.2× 1.5k 1.7× 426 0.6× 671 1.0× 376 0.6× 214 7.8k
Janet E. Hux Canada 37 266 0.2× 1.1k 1.3× 256 0.4× 836 1.3× 399 0.6× 71 6.7k

Countries citing papers authored by David Wright

Since Specialization
Citations

This map shows the geographic impact of David Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wright more than expected).

Fields of papers citing papers by David Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wright. The network helps show where David Wright may publish in the future.

Co-authorship network of co-authors of David Wright

This figure shows the co-authorship network connecting the top 25 collaborators of David Wright. A scholar is included among the top collaborators of David Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wright. David Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rolnik, Daniel L., Liona C. Poon, Argyro Syngelaki, et al.. (2025). Aspirin, Birthweight, and Large‐For‐Gestational‐Age Neonates: A Secondary Analysis of the ASPRE Trial. BJOG An International Journal of Obstetrics & Gynaecology. 132(11). 1606–1614.
2.
Syngelaki, Argyro, S. Marina, Laura A. Magee, et al.. (2025). Prevent-PE (pre-eclampsia prevention by timed birth at term): Protocol for a randomised trial. Pregnancy Hypertension. 40. 101211–101211. 1 indexed citations
3.
Wright, David, et al.. (2025). Barriers and enablers to medicine-taking behaviours in chronic obstructive pulmonary disease: a qualitative interview study. International Journal of Clinical Pharmacy. 47(3). 775–783.
4.
Irvine, Lisa, Jennifer Kirsty Burton, Myzoon Ali, et al.. (2024). Data Resource Profile: the Virtual International Care Homes Trials Archive (VICHTA). International Journal for Population Data Science. 8(6). 2161–2161. 2 indexed citations
5.
Barnett, Julie, et al.. (2022). Designing a theory and evidence informed pharmacogenomic testing service in community pharmacy in England. Research in Social and Administrative Pharmacy. 18(10). 3831–3838. 5 indexed citations
6.
Wright, David, et al.. (2021). Estimating the potential impact of implementing pre‐emptive pharmacogenetic testing in primary care across the UK. British Journal of Clinical Pharmacology. 87(7). 2907–2925. 26 indexed citations
7.
Wright, David, et al.. (2020). Pharmacogenomic testing and its future in community pharmacy. Pharmaceutical journal/˜The œpharmaceutical journal. 304(7933). 52–57. 1 indexed citations
8.
Twigg, Michael, et al.. (2018). The pharmacy care plan service: Evaluation and estimate of cost-effectiveness. Research in Social and Administrative Pharmacy. 15(1). 84–92. 22 indexed citations
9.
Bond, Christine, Kathleen Lane, Fiona Poland, et al.. (2016). GP views on the potential role of pharmacist independent prescribers within care homes: care homes independent pharmacist prescribing study (CHIPPS): ‘there has to be something in it for me’.. International Journal of Pharmacy Practice. 14–14. 1 indexed citations
10.
Wright, David, Lyanne Brouwer, Maria‐Elena Mannarelli, et al.. (2015). Social pairing of Seychelles warblers under reduced constraints: MHC, neutral heterozygosity, and age. Behavioral Ecology. 27(1). 295–303. 6 indexed citations
11.
Watson, Margaret, James Ferguson, Garry Barton, et al.. (2015). A cohort study of influences, health outcomes and costs of patients’ health-seeking behaviour for minor ailments from primary and emergency care settings. BMJ Open. 5(2). e006261–e006261. 97 indexed citations
12.
Watson, Steven James, et al.. (2012). The impact of motivational interviewing (MI) as an intervention to improve medication adherence : a meta-analysis. Lancaster EPrints (Lancaster University). 1 indexed citations
13.
Christou, María & David Wright. (2011). Engendering and appraising professionalism within the UK pharmacy pre-registration year: Identifying the current barriers. Pharmacy Education. 11. 2 indexed citations
14.
Kelly, Jennifer, et al.. (2010). Administering medication to adult patients with dysphagia:part 2. Nursing Standard. 24(26). 61–68. 16 indexed citations
15.
Holst, Lone, David Wright, Svein Haavik, & Hedvig Nordeng. (2009). The Use and the User of Herbal Remedies During Pregnancy. The Journal of Alternative and Complementary Medicine. 15(7). 787–792. 133 indexed citations
16.
Wright, David. (2006). Tender evaluation for Gateway upgrade project.
17.
Wright, David. (1982). LEGAL PROTECTION FOR MICROBIOLOGICAL AND GENETIC ENGINEERING INVENTIONS.. Biotechnology Law Report. 1(5-7). 103–104. 1 indexed citations
18.
Ross, Omri, et al.. (1973). Future of the B.M.A. BMJ. 1(5848). 297.5–297. 2 indexed citations
19.
Wright, David, et al.. (1970). Nifuratel for trichomonal vaginitis.. BMJ. 2(5708). 542.2–542. 4 indexed citations
20.
Wright, David, et al.. (1969). Trimethoprim mixture.. BMJ. 1(5644). 637.1–637. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026